Results 181 to 190 of about 15,557 (223)
Construction and diagnostic efficacy assessment of the urinary exosomal miRNA-mRNA network in children with IgA vasculitis nephritis. [PDF]
FASEB JZhang Y +14 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Current Opinion in Pediatrics, 2022
Purpose of review The purpose of this update is to summarize current knowledge on the pathophysiology of immunglobulin A (IgA) vasculitis nephritis (IgAVN) as well as to critically review evidence for established therapeutic regimes and available biomarkers. An additional purpose is to raise the discussion what could be done to
Eva, Nüsken, Lutz T, Weber
openaire +2 more sources
Purpose of review The purpose of this update is to summarize current knowledge on the pathophysiology of immunglobulin A (IgA) vasculitis nephritis (IgAVN) as well as to critically review evidence for established therapeutic regimes and available biomarkers. An additional purpose is to raise the discussion what could be done to
Eva, Nüsken, Lutz T, Weber
openaire +2 more sources
Geospatial clustering of childhood IgA vasculitis and IgA vasculitis-associated nephritis
Annals of the Rheumatic Diseases, 2021Research on spatial variability of the incidence of IgA vasculitis (IgAV) in children and its potential implications for elucidation of the multifactorial aetiology and pathogenesis is limited. We intended to observe spatial variability of the incidence of IgAV and IgA vasculitis-associated nephritis (IgAVN) using modern geostatistical methods, and ...
Matej Sapina +10 more
openaire +3 more sources
IgA vasculitis induced by acenocoumarol
Reumatología Clínica (English Edition), 2020We present the case of a 73-year-old man with IgA vasculitis after administration of acenocoumarol, confirmed by anatomopathological study. He had cutaneous, joint and renal involvement. With the reintroduction of the drug, the clinical manifestations worsened. They were completely resolved with its suspension, without additional maintenance treatment.
Sara, Esteban Terradillos +5 more
openaire +2 more sources
IgA vasculitis during secukinumab therapy
Clinical Rheumatology, 2020Psoriatic arthritis is a chronic, seronegative spondyloarthropathy associated with psoriasis, depending on patient presentation treatment options range from non-pharmacologic measures to NSAIDs, DMARDs, and biologics. Secukinumab is a human monoclonal antibody that specifically targets interleukin-17 and has been shown to be highly effective in the ...
Dijana Perkovic +2 more
openaire +3 more sources
Multisystemic manifestations of IgA vasculitis
Clinical Rheumatology, 2020Immunoglobulin A vasculitis (IgAV), also known as Henoch-Schönlein Purpura, is one of the most common kind of systemic vasculitis in children, and due to the involvement of small blood vessels throughout the body, this disease can cause a variety of symptoms in different organs. Our aim was to review the data on various systemic manifestations of IgAV.
Lina Du +5 more
openaire +2 more sources
Management of IgA Vasculitis with Nephritis
Pediatric Drugs, 2021Immunoglobulin A (IgA) vasculitis (IgAV), previously called Henoch-Schönlein purpura, is characterized by IgA-dominant immune deposits affecting small vessels and often involves the skin, gastrointestinal tract, joints, and kidneys. IgAV is the most common cause of systemic vasculitis in children.
Jean-Daniel, Delbet +4 more
openaire +2 more sources
IgA vasculitis with severe renal manifestation
BMJ Case Reports, 2022IgA vasculitis is a rare systemic vasculitis in adults, frequently more severe than in paediatric age. It manifests with cutaneous, articular, gastrointestinal and renal involvement. We present a case of a man in his 40s diagnosed with IgA vasculitis with cutaneous, joint, gastrointestinal and renal disease.
Joana, Marques Dias +3 more
openaire +2 more sources